×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Wedbush Maintains Viridian Therapeutics (VRDN) Outperform Recommendation
MSN
Fintel reports that on July 11, 2023, Wedbush maintained coverage of Viridian Therapeutics (NASDAQ:VRDN) with a Outperform recommendation.
6 hours ago
Viridian Therapeutics Inc (VRDN) Q1 2024 Earnings: Narrowing Losses Amidst Clinical Advancements
Yahoo Finance
Revenue: Reported at $72,000 for Q1 2024, surpassing the estimated $70,000. Net Loss: Recorded at $48.54 million for Q1 2024,...
2 weeks ago
Viridian Therapeutics (NASDAQ:VRDN) Stock Price Down 5%
Defense World
Viridian Therapeutics, Inc. (NASDAQ:VRDN – Get Free Report)'s stock price fell 5% during mid-day trading on Friday . The stock traded as low...
3 days ago
Viridian Therapeutics to Participate in Upcoming May Investor Conferences
Business Wire
Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company focused on discovering and developing potential best-in-class...
1 week ago
VIRIDIAN SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Viridian Therapeutics, Inc. (VRDN ...
PR Newswire
PRNewswire/ -- Kaskela Law LLC announces that it is investigating Viridian Therapeutics, Inc. (NASDAQ: VRDN) ("Viridian") on behalf of the...
1 month ago
Viridian Therapeutics, Inc. (VRDN) Reports Q1 Loss, Misses Revenue Estimates
Zacks Investment Research
Viridian Therapeutics (VRDN) delivered earnings and revenue surprises of 26.17% and 10%, respectively, for the quarter ended March 2024.
2 weeks ago
Viridian Therapeutics, Inc. (NASDAQ:VRDN) Stock Holdings Boosted by New York State Common Retirement Fund
Defense World
Read Viridian Therapeutics, Inc. (NASDAQ:VRDN) Stock Holdings Boosted by New York State Common Retirement Fund at Defense World.
6 days ago
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire
Viridian Therapeutics, Inc. (Nasdaq: VRDN) (the “company” or “Viridian”), a biopharmaceutical company focused on discovering and developing...
2 months ago
Does Viridian Therapeutics (NASDAQ:VRDN) Have A Healthy Balance Sheet?
Yahoo
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
2 days ago
Viridian Therapeutics Highlights Recent Progress and Reports First Quarter 2024 Financial Results
Business Wire
Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in-class medicines...
2 weeks ago